Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Tellus' lead candidate, TT-20, induces regeneration of myelin-producing oligodendrocytes, reverses white matter injury in an animal models of perinatal brain injury and multiple sclerosis and is pursuing a novel regulatory path to evaluate safety and efficacy in newborns with brain injury.
View Top Employees from Tellus Therapeutics, Inc| Website | http://www.tellustherapeutics.com |
| Employees | 9 (8 on RocketReach) |
| Founded | 2018 |
| Address | 8 Davis Drive, Durham, North Carolina 27709, US |
| Phone | (919) 491-4995 |
| Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Business Services |
| Competitors | Q Therapeutics, Virscio |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies |
Looking for a particular Tellus Therapeutics, Inc employee's phone or email?
Tellus Therapeutics, Inc Questions
Eric Benner is the Co-Founder, Chief Scientific Officer of Tellus Therapeutics, Inc.
8 people are employed at Tellus Therapeutics, Inc.
Tellus Therapeutics, Inc is based in Durham, North Carolina.
The NAICS codes for Tellus Therapeutics, Inc are [541, 54171, 54, 5417, 541714].
The SIC codes for Tellus Therapeutics, Inc are [873, 87].
Top Tellus Therapeutics, Inc Employees
-
25+
-
5+2
-
5+4
-
ViewAustin Schwartz
Vice President of Operations at Tellus Therapeutics, Inc
Durham, North Carolina, United States22 -
1
Related Companies
